phenyl acetate has been researched along with Coronary Disease in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (39.13) | 18.7374 |
1990's | 25 (36.23) | 18.2507 |
2000's | 13 (18.84) | 29.6817 |
2010's | 4 (5.80) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Holmes, MV; Talmud, PJ | 1 |
Fraser, H; Hislop, C; Rosenson, RS; Trias, J | 1 |
Elliott, M; Hislop, C; Rosenson, RS; Stasiv, Y | 1 |
Arsenault, BJ; Boekholdt, SM; Kastelein, JJ | 1 |
Berdan, L; Califf, RM; Dyke, C; Gallup, D; Harrington, RA; Lauer, MS; Mahaffey, KW; Mänttäri, M; Moliterno, DJ; Mukherjee, D; Pieper, KS; Roe, MT; Topol, EJ; White, HD; Yadav, JS | 1 |
Armstrong, PW; Califf, RM; Christenson, RH; Fu, Y; Harrington, RA; Hasselblad, V; Kaul, P; Mahaffey, KW; Newby, LK; Ohman, EM; Topol, EJ; Van de Werf, F | 1 |
Armstrong, PW; Califf, RM; Fu, Y; Harrington, RA; Hersi, A; Mahaffey, KW; Van de Werf, F; Wong, B | 1 |
Bhapkar, MV; Califf, RM; Davis, CG; Granger, CB; Harrington, RA; Hochman, JS; Moliterno, DJ; Newby, LK; Simes, RJ; Topol, EJ; Van de Werf, F | 1 |
Boersma, E; Westerhout, CM | 2 |
ARCURI, F; PORTA, A | 1 |
MUSCARI, A | 1 |
COLI, R; DE LIPERI, E | 1 |
ANSON, JH; DIRSTINE, PH; MACCALLUM, DB; MOHAMMED, A | 1 |
Alanen, KA; Lipasti, JA; Nevalainen, TJ; Tolvanen, MA | 1 |
Gercken, G; Trotz, M | 1 |
Allan, RM; Eakins, MN; Pike, VW; Selwyn, AP | 1 |
Cowan, JC; Williams, EM | 1 |
Fujibayashi, Y; Kawamoto, M; Konishi, J; Magata, Y; Nohara, R; Sasayama, S; Tadamura, E; Tamaki, N; Yonekura, Y | 1 |
Friend, KD; Harakal, C; Kukulka, SP; Lilford, K; Tomera, JF | 1 |
Jain, D; Zaret, BL | 1 |
Bergmann, SR; Conversano, A; Geltman, EM; Gropler, RJ; Pérez, JE; Sampathkumaran, K; Schechtman, KB; Siegel, BA; Sobel, BE | 1 |
Schwaiger, M; von Schulthess, GK | 1 |
Bol, A; Degrieck, Y; Heyndrickx, GR; Melin, JA; Vandeplassche, G; Vogelaers, D; Wijns, W | 1 |
Verheugt, FW | 1 |
Gawaz, M; Neumann, FJ; Schömig, A | 1 |
Adgey, AA | 2 |
Ferguson, JJ; Lau, TK | 1 |
Armstrong, PW; Braunwald, E; Califf, RM; Gibler, WB; Hamm, CW; Maseri, A; Simoons, ML; Van de Werf, F | 1 |
Alexander, JH; Harrington, RA | 1 |
Berry, JJ; Schwaiger, M | 1 |
Kaluza, G; Kleiman, NS; Mazur, W | 1 |
Phillips, J; Stouffer, GA; Subbarao, VD | 1 |
Califf, RM; Lincoff, AM; Topol, EJ | 1 |
Blankenship, JC; Frey, CM; Memon, MA; Menapace, FJ; Wood, GC | 1 |
Jang, IK; Sabatine, MS | 1 |
Berkowitz, SD | 1 |
Armstrong, PW; Califf, RM; Christenson, RH; Harrington, RA; Hasselblad, V; Moliterno, DJ; Newby, LK; Ohman, EM; Pfisterer, M; Topol, EJ; Van De Werf, F; White, HD | 1 |
SoRelle, R | 1 |
Bricknell, OL; Opie, LH | 1 |
Miller, NE; Mjos, OD; Oliver, MF; Riemersma, RA | 1 |
Mjos, OD | 1 |
Buxton, DB; Krivokapich, J; Mody, FV; Phelps, ME; Schelbert, HR | 1 |
Cavagna, F; Daprà, M; de Haën, C; Felder, E; Maggioni, F | 1 |
Geltman, EM; Gropler, RJ; Siegel, BA | 1 |
Brunken, RC; Chan, SY; Phelps, ME; Schelbert, HR | 1 |
Chatelain, P; Görge, G; Lerch, R; Schaper, J | 1 |
Cavallini, L; Rigobello, MP; Valente, M | 1 |
Dennis, S; Opie, LH; Owen, P | 1 |
Johnston, DL; Lewandowski, ED | 1 |
Mizushima, M | 1 |
Hearse, DJ; Kempsford, RD | 1 |
Bünger, R; Hartman, DA; Mallet, RT | 1 |
Burns, AH; Racey-Burns, LA; Shepherd, RE; Summer, WR | 1 |
Levy, LA; London, RE; Murphy, E; Raju, B; Steenbergen, C | 1 |
Toleĭkis, AI | 1 |
Bergmann, SR; Brown, M; Marshall, DR; Sobel, BE | 1 |
Feldman, RL; Hill, JA; MacDonald, RG; Pepine, CJ; Stacpoole, PW; Wargovich, TJ | 1 |
Martynov, AI; Savenkov, PM; Zadionchenko, VS | 1 |
Berezovskii, RN; Solomonova, LN; Sukasova, TI | 1 |
Bencze, WL; DeStevens, G; Hess, R | 1 |
Avezou, F; Denis, B; Mallion, JM; Martin-Noel, P | 1 |
Detry, R; Dupont, JC; Pont, M; Sambin, P | 1 |
Artuso, P; Chierici, F; Suriani, L | 1 |
Bajolle, F; Borel, JP; Deville, A | 1 |
Blankenhorn, DH; Chin, HP | 1 |
20 review(s) available for phenyl acetate and Coronary Disease
Article | Year |
---|---|
Deciphering the Causal Role of sPLA2s and Lp-PLA2 in Coronary Heart Disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetates; Animals; Benzaldehydes; Biomarkers; Coronary Disease; Humans; Indoles; Keto Acids; Molecular Targeted Therapy; Oximes; Phospholipase A2 Inhibitors; Phospholipases A2, Secretory; Signal Transduction; Treatment Outcome | 2015 |
Varespladib methyl in cardiovascular disease.
Topics: Acetates; Animals; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Humans; Indoles; Inflammation; Keto Acids; Male; Phospholipases A2, Secretory | 2010 |
Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Coronary Disease; Drug Evaluation; Eptifibatide; Guidelines as Topic; Humans; Immunoglobulin Fab Fragments; Incidence; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Assessment; Tirofiban; Treatment Outcome; Tyrosine | 2003 |
Intravenous glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: lessons from recently conducted randomized clinical trials.
Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine | 2004 |
Nuclear imaging techniques for the assessment of myocardial viability.
Topics: Acetates; Carbon Radioisotopes; Coronary Disease; Deoxyglucose; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Iodine Radioisotopes; Male; Myocardial Stunning; Sodium Pertechnetate Tc 99m; Thallium Radioisotopes; Tomography, Emission-Computed | 1995 |
[Clinical indications for PET of the heart].
Topics: Acetates; Cardiomyopathies; Coronary Disease; Deoxyglucose; Fatty Acids; Fluorodeoxyglucose F18; Humans; Myocardial Infarction; Myocardium; Tomography, Emission-Computed | 1993 |
[Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
Topics: Abciximab; Acetates; Alkynes; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Binding Sites; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Coronary Disease; Double-Blind Method; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Randomized Controlled Trials as Topic; Receptors, Antigen, B-Cell; Receptors, Cell Surface; Time Factors; Tirofiban; Tyrosine | 1997 |
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Eptifibatide; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
New antiplatelet agents for acute coronary syndromes.
Topics: Abciximab; Acetates; Acute Disease; Antibodies, Monoclonal; Blood Platelets; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Injections, Intravenous; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 1998 |
An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Atherectomy, Coronary; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Heparin; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Disease; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Thrombolytic Therapy; Tirofiban; Treatment Outcome; Tyrosine | 1998 |
Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
Topics: Acetates; Acute Disease; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Tirofiban; Tyrosine | 1998 |
Metabolic imaging with positron-emission tomography.
Topics: Acetates; Cardiomyopathies; Catecholamines; Coronary Disease; Deoxyglucose; Forecasting; Humans; Misonidazole; Radioisotopes; Tomography, Emission-Computed | 1990 |
Antiplatelet therapy for treatment of acute coronary syndromes.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Aspirin; Clopidogrel; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Vascular Patency | 1999 |
Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Angina, Unstable; Antibodies, Monoclonal; Clinical Trials as Topic; Coronary Disease; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Tyrosine | 1999 |
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.
Topics: Abciximab; Acetates; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Combined Modality Therapy; Coronary Disease; Drug Monitoring; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Infusions, Intravenous; Myocardial Infarction; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Practice Guidelines as Topic; Recurrence; Risk Factors; Tirofiban; Treatment Outcome; Tyrosine | 2000 |
Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: a pooled analysis of major clinical trials.
Topics: Abciximab; Acetates; Acute Disease; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Drug Therapy, Combination; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Incidence; Infusions, Intravenous; Intracranial Hemorrhages; Odds Ratio; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Syndrome; Tirofiban; Tyrosine | 2000 |
The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
Topics: Abciximab; Acetates; Acute Disease; Administration, Oral; Alanine; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Coronary Disease; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Myocardial Infarction; Oximes; Peptides; Piperidines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrrolidines; Randomized Controlled Trials as Topic; Stents; Syndrome; Thrombocytopenia; Thrombolytic Therapy; Tirofiban; Tyrosine | 2000 |
Current knowledge of the platelet glycoprotein IIb/IIIa receptor antagonists for the treatment of coronary artery disease.
Topics: Abciximab; Acetates; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Antibodies, Monoclonal; Coronary Artery Bypass; Coronary Disease; Drug Approval; Eptifibatide; Hemorrhage; Humans; Immunoglobulin Fab Fragments; Mice; Multicenter Studies as Topic; Myocardial Ischemia; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Recurrence; Safety; Single-Blind Method; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine; United States; United States Food and Drug Administration | 2000 |
Hypolipidemic agents.
Topics: Acetates; Adult; Animals; Azoles; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Diet; Dogs; Esters; Estrogens; Female; Haplorhini; Heart Diseases; Humans; Hypolipidemic Agents; Lipids; Lipoproteins; Male; Mevalonic Acid; Mice; Middle Aged; Nicotinic Acids; Oxazoles; Prostaglandins; Pyrazoles; Pyridines; Rats; Steroids; Thyroxine | 1969 |
7 trial(s) available for phenyl acetate and Coronary Disease
Article | Year |
---|---|
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease.
Topics: Acetates; Aged; Apolipoproteins B; C-Reactive Protein; Cholesterol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Keto Acids; Male; Phospholipases A2, Secretory; Triglycerides | 2011 |
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
Topics: Acetates; Acute Disease; Aged; Anticoagulants; Coronary Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Myocardial Revascularization; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Randomized Controlled Trials as Topic; Survival Analysis; Tyrosine | 2002 |
Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Risk Assessment; Syndrome; Time Factors; Troponin T; Tyrosine | 2003 |
Does the discharge ECG provide additional prognostic insight(s) in non-ST elevation ACS patients from that acquired on admission?
Topics: Acetates; Acute Disease; Aged; Arrhythmias, Cardiac; Coronary Disease; Disease-Free Survival; Electrocardiography; Female; Hospitalization; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prognosis; Survival Analysis; Troponin T; Tyrosine | 2003 |
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.
Topics: Acetates; Acute Disease; Aged; Aged, 80 and over; Coronary Disease; Female; Heparin; Humans; Infusions, Intravenous; Logistic Models; Male; Middle Aged; Monitoring, Physiologic; Odds Ratio; Partial Thromboplastin Time; Point-of-Care Systems; Syndrome; Tyrosine | 2002 |
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Hemorrhage; Humans; Infusions, Intravenous; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Secondary Prevention; Survival Rate; Treatment Outcome; Troponin T; Tyrosine | 2001 |
Randomized, placebo-controlled trial of titrated intravenous lamifiban for acute coronary syndromes.
Topics: Acetates; Acute Disease; Aged; Coronary Disease; Double-Blind Method; Endpoint Determination; Female; Hemorrhage; Humans; Incidence; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Titrimetry; Treatment Outcome; Tyrosine | 2002 |
42 other study(ies) available for phenyl acetate and Coronary Disease
Article | Year |
---|---|
Varespladib: targeting the inflammatory face of atherosclerosis.
Topics: Acetates; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Keto Acids; Male; Phospholipases A2, Secretory | 2011 |
THYROID hormones and coronary disease.
Topics: Acetates; Blood; Cholesterol; Coronary Disease; Thyroid Hormones; Thyroxine | 1956 |
[Clinical observations on the action of diisopropylammonium dichloroacetate in coronary diseases].
Topics: Acetates; Ammonium Compounds; Coronary Disease; Humans; Quaternary Ammonium Compounds | 1960 |
[Clinical contribution to the use of DIEDI (SI-401)].
Topics: Acetates; Ammonium Compounds; Anti-Arrhythmia Agents; Coronary Disease; Enzyme Inhibitors; Humans; Quaternary Ammonium Compounds | 1960 |
[Dichloroethanoate of diisopropylammonium in the treatment of chronic coronary disease].
Topics: Acetates; Ammonium Compounds; Coronary Disease; Heart Diseases; Quaternary Ammonium Compounds | 1963 |
OPTIMUM CLINICAL APPLICATION OF SERUM PROTEIN ELECTROPHORESIS.
Topics: Acetates; Blood Protein Electrophoresis; Blood Proteins; Cellulose; Coronary Disease; Electrophoresis; Humans; Nephrotic Syndrome; Physical Examination; Statistics as Topic | 1964 |
Anaerobic glycolysis and the development of ischaemic contracture in isolated rat heart.
Topics: Acetates; Adenosine Triphosphate; Anaerobiosis; Animals; Coronary Disease; Glucose; Glycolysis; In Vitro Techniques; Myocardial Contraction; Myocardium; Oxygen; Perfusion; Rats; Rats, Inbred Strains | 1984 |
Fatty acid synthesis in the arrested rabbit heart during ischemia.
Topics: Acetates; Acetylcarnitine; Animals; Coronary Disease; Fatty Acids; Glycerides; Heart Arrest, Induced; Kinetics; Lipid Metabolism; Myocardium; Phospholipids; Rabbits | 1983 |
Preparation of [1-11C]acetate--an agent for the study of myocardial metabolism by positron emission tomography.
Topics: Acetates; Carbon Radioisotopes; Coronary Disease; Humans; Isotope Labeling; Myocardium; Tomography, Emission-Computed | 1982 |
The effects of various fatty acids on action potential shortening during sequential periods of ischaemia and reperfusion.
Topics: Acetates; Action Potentials; Adenine Nucleotides; Animals; Caprylates; Coronary Disease; Fatty Acids, Nonesterified; Glycogen; Guinea Pigs; Heart; Humans; Linoleic Acids; Palmitic Acids; Phosphocreatine | 1980 |
Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
Topics: Acetates; Carbon Radioisotopes; Coronary Disease; Decanoic Acids; Deoxyglucose; Fatty Acids; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardium; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
Calcium accumulation in experimental hypertension.
Topics: Acetates; Analysis of Variance; Animals; Aorta; Blood Pressure; Cadmium; Calcium; Coronary Disease; Disease Models, Animal; Drinking; Female; Heart Ventricles; Hypertension; Hypertension, Renal; Hypertrophy, Left Ventricular; Kidney; Kidney Cortex; Kidney Medulla; Nephrectomy; Rabbits; Reproducibility of Results; Spectrophotometry, Atomic; Tissue Distribution | 1995 |
Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography.
Topics: Acetates; Acetic Acid; Adult; Aged; Carbon Radioisotopes; Coronary Circulation; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Revascularization; Oxidation-Reduction; Predictive Value of Tests; Systole; Tomography, Emission-Computed | 1993 |
Recovery of regional contractile function and oxidative metabolism in stunned myocardium induced by 1-hour circumflex coronary artery stenosis in chronically instrumented dogs.
Topics: Acetates; Animals; Constriction, Pathologic; Coronary Angiography; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Myocardial Contraction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Tomography, Emission-Computed | 1993 |
In search of a superaspirin for the heart.
Topics: Abciximab; Acetates; Antibodies, Monoclonal; Anticoagulants; Coronary Disease; Eptifibatide; Fibrinolytic Agents; Humans; Immunoglobulin Fab Fragments; Peptides; Platelet Aggregation Inhibitors; Tirofiban; Tyrosine | 1997 |
Platelet glycoprotein IIb/IIIa inhibitor effect examined in 2 studies.
Topics: Acetates; Acute Disease; Angina, Unstable; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Eptifibatide; Humans; Peptides; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prognosis; Syndrome; Treatment Outcome; Tyrosine | 2002 |
Effects of substrates on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion.
Topics: Acetates; Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Coronary Disease; Cyclic AMP; Glucose; L-Lactate Dehydrogenase; Palmitates; Pyruvates; Rats | 1978 |
Effects of dichloroacetate on myocardial substrate extraction, epicardial ST-segment elevation, and ventricular blood flow following coronary occlusion in dogs.
Topics: Acetates; Animals; Blood Glucose; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Fatty Acids, Nonesterified; Female; Glucose; Heart; Heart Rate; Isoproterenol; Lactates; Male; Myocardium; Time Factors | 1976 |
Effect of reduction of myocardial free fatty acid metabolism relative to that of glucose on the ischemic injury during experimental coronary artery occlusion in dogs.
Topics: Acetates; Acute Disease; Albumins; Animals; Butyrates; Coronary Disease; Dogs; Fatty Acids, Nonesterified; Glucose; Myocardium; Nicotinyl Alcohol; Prostaglandins E | 1976 |
Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium.
Topics: Acetates; Animals; Coronary Circulation; Coronary Disease; Dogs; Glucose; Heart; Myocardial Reperfusion; Myocardium; Oxygen Consumption; Palmitates; Tomography, Emission-Computed | 1992 |
Gd-BOPTA/Dimeg: experimental disease imaging.
Topics: Acetates; Animals; Contrast Media; Coronary Disease; Gadolinium; Gadolinium DTPA; Liver Neoplasms, Experimental; Meglumine; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1991 |
Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow.
Topics: Acetates; Acetic Acid; Adult; Aged; Carbon Radioisotopes; Coronary Circulation; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardium; Tomography, Emission-Computed | 1991 |
Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion.
Topics: Acetates; Aged; Ammonia; Carbon Radioisotopes; Coronary Circulation; Coronary Disease; Female; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Tomography, Emission-Computed | 1991 |
Effect of increasing degrees of ischemic injury on myocardial oxidative metabolism early after reperfusion in isolated rat hearts.
Topics: Acetates; Animals; Coronary Disease; Energy Metabolism; Glucose; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Oxidation-Reduction; Oxygen Consumption; Palmitates; Phosphates; Rats | 1991 |
The protective action of pyruvate on recovery of ischemic rat heart: comparison with other oxidizable substrates.
Topics: Acetates; Animals; Coronary Disease; Energy Metabolism; Glucose; Heart; Insulin; Lactates; Lactic Acid; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Oxidation-Reduction; Pyruvates; Pyruvic Acid; Rats | 1990 |
Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts.
Topics: Acetates; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Fatty Acids, Nonesterified; Glucose; Glycogen; Heart; Lactates; Lactic Acid; Male; Myocardial Contraction; Phosphocreatine; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Reduced substrate oxidation in postischemic myocardium: 13C and 31P NMR analyses.
Topics: Acetates; Animals; Carbon Isotopes; Coronary Disease; Heart; Hemodynamics; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion; Myocardium; Oxidation-Reduction; Phosphorus; Pyruvates; Rabbits | 1990 |
[Effects of dichloroacetate in the ischemic heart. Analysis of hemodynamics, myocardial energy metabolism and myocardial pH].
Topics: Acetates; Adenine Nucleotides; Animals; Coronary Disease; Dichloroacetic Acid; Dogs; Energy Metabolism; Glycolysis; Hemodynamics; Hydrogen-Ion Concentration; Myocardium; Phosphocreatine | 1990 |
Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart.
Topics: Acetates; Animals; Animals, Newborn; Bicarbonates; Calcium Chloride; Cardiac Output; Cardioplegic Solutions; Coronary Disease; Gluconates; Glucose; Heart; Heart Rate; Magnesium; Magnesium Chloride; Mannitol; Potassium Chloride; Procaine; Rabbits; Sodium Acetate; Sodium Chloride; Stroke Volume | 1989 |
Pyruvate-enhanced phosphorylation potential and inotropism in normoxic and postischemic isolated working heart. Near-complete prevention of reperfusion contractile failure.
Topics: Acetates; Animals; Coronary Circulation; Coronary Disease; Coronary Vessels; Cytosol; Energy Metabolism; Glucose; Guinea Pigs; Heart; Hemodynamics; Lactates; Male; Myocardial Contraction; Norepinephrine; Oxidation-Reduction; Perfusion; Phosphorylation; Pyruvates; Pyruvic Acid | 1989 |
The effect of dichloroacetate on the isolated no flow arrested rat heart.
Topics: Acetates; Adenosine Triphosphate; Animals; Coronary Circulation; Coronary Disease; Dichloroacetic Acid; In Vitro Techniques; Lactates; Male; Myocardial Contraction; Myocardium; Phosphocreatine; Pyruvate Dehydrogenase Complex; Rats | 1989 |
Cytosolic free magnesium levels in ischemic rat heart.
Topics: Acetates; Aminophenols; Animals; Chelating Agents; Coronary Disease; Cytosol; Fluorine; Magnesium; Magnetic Resonance Spectroscopy; Male; Myocardium; Perfusion; Rats; Rats, Inbred Strains; Reference Values | 1989 |
[Mechanism of ischemic disorders of fatty acid oxidation in heart mitochondria].
Topics: Acetates; Animals; Caproates; Citric Acid Cycle; Coronary Disease; Cytochrome c Group; Fatty Acids; In Vitro Techniques; Mitochondria, Heart; Oxidation-Reduction; Palmitoyl Coenzyme A; Palmitoylcarnitine; Rabbits | 1985 |
Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.
Topics: Acetates; Animals; Carbon Dioxide; Carbon Radioisotopes; Coronary Disease; Glucose; Half-Life; Heart; Hemodynamics; Humans; Isoproterenol; Lactates; Male; Myocardium; Oxygen Consumption; Rabbits; Tomography, Emission-Computed | 1987 |
Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease.
Topics: Acetates; Aged; Cardiac Catheterization; Coronary Disease; Dichloroacetic Acid; Female; Heart; Hemodynamics; Humans; Lactates; Male; Middle Aged | 1988 |
[Use of recordil-30 in arteriosclerosis of the arteries of the heart, brain and lower extremities].
Topics: Acetates; Adult; Aged; Arteriosclerosis; Blood Pressure Determination; Blood Protein Electrophoresis; Cholesterol; Chronic Disease; Coronary Disease; Electrocardiography; Female; Flavonoids; Humans; Hypertension; Intracranial Arteriosclerosis; Leg; Lipids; Male; Middle Aged; Phospholipids; Plethysmography, Impedance; Tablets | 1974 |
[Treatment of chronic coronary insufficiency with recordil].
Topics: Acetates; Chronic Disease; Coronary Disease; Female; Flavonoids; Humans; Lipid Metabolism; Male; Vasodilator Agents | 1974 |
[Study of the action of Vibeline 100 on coronary angor].
Topics: Acetates; Aged; Angina Pectoris; Benzopyrans; Butyrates; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
[Effect on lipid metabolism of a coronary dilator: ethyl-7-oxyacetate flavone].
Topics: Acetates; Aged; Coronary Disease; Drug Synergism; Female; Flavonoids; Heart Diseases; Humans; Lipid Metabolism; Male; Middle Aged; Vasodilator Agents | 1969 |
[Clinical results of the use of a new drug association in heart diseases].
Topics: Acetates; Adult; Aged; Amobarbital; Angina Pectoris; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pentaerythritol Tetranitrate; Propylamines | 1970 |
[Electrophoresis of lactic dehydrogenase (L.D.H.) isoenzymes on cellulose acetate. Technic and results].
Topics: Acetates; Animals; Cellulose; Coronary Disease; Electrophoresis; Heart Diseases; Isoenzymes; L-Lactate Dehydrogenase; Liver Cirrhosis; Liver Neoplasms; Methods; Muscles; Myocardial Infarction; Rabbits | 1968 |
On the precision of lipoprotein electrophoresis on cellulose acetate and its use in the diagnosis of hyperlipoproteinemia.
Topics: Acetates; Adult; Blood Protein Disorders; Cellulose; Coronary Disease; Electrophoresis; Fasting; Female; Humans; Lipoproteins; Male; Methods; Myocardial Infarction; Time Factors | 1969 |